Clinical Trials
7
Active:0
Completed:7
Trial Phases
2 Phases
Phase 3:2
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
4 (66.7%)Phase 3
2 (33.3%)The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study
Phase 3
Completed
- Conditions
- Diabetic Foot Ulcer of Neuropathic Origin
- Interventions
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Olympus Biotech Corporation
- Target Recruit Count
- 207
- Registration Number
- NCT01217476
- Locations
- ππΊ
LL, Budapest, Hungary
ππΊPF, Budapest, Hungary
πΈπͺML, Malmo 20502, Sweden
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study
Phase 3
Completed
- Conditions
- Diabetic Foot Ulcer of Neuropathic Origin
- Interventions
- First Posted Date
- 2010-10-08
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- Olympus Biotech Corporation
- Target Recruit Count
- 201
- Registration Number
- NCT01217463
OP Device vs. Bone Autograft for the Treatment of Tibial Nonunions
Not Applicable
Completed
- Conditions
- Tibial Nonunions
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Olympus Biotech Corporation
- Target Recruit Count
- 122
- Registration Number
- NCT00679328
A Prospective Pilot Study of the OP-1 Putty in Uninstrumented Posterolateral Fusions
Not Applicable
Completed
- Conditions
- Degenerative Lumbar Spondylolisthesis
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Olympus Biotech Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT00679107
OP-1 Putty for Posterolateral Fusions
Not Applicable
Completed
- Conditions
- Degenerative Lumbar Spondylolisthesis
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Olympus Biotech Corporation
- Target Recruit Count
- 336
- Registration Number
- NCT00677950
- Prev
- 1
- 2
- Next
News
No news found